GFAP and Alzheimer disease: In patients with AD and PD, glial fibrillary acidic protein (GFAP) released from active astrocytes and ionized calcium-binding adaptor molecule 1 (Iba1) from active microglia under neuroinflammation are associated with loss of myelin and increased soluble tau level in neurons [63].